Reading DEA? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.

QuarterlyIQ Insights · DEA

Price

Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.

Price

Daily closes. Earnings/event dots inline.

Close 2026-06-12

Adjusted daily closes (split & dividend). Scroll over the chart to zoom; click a range to reset.

EarningsMaterial event

What it's worth (estimated)

A consensus fair price across 5 valuation methods, at three horizons. Current price $24.04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.

12-month· primaryexpensive

$17.25consensus

Range $6.73 – $40.39

vs price: +39% above

Method agreement — · 5 methods

No-growth: today's peer multiple on trailing earnings. The headline read.

3-yearinexpensive

$48.23consensus

Range $47.15 – $49.32

vs price: -50% below

Method agreement — · 2 methods

Embeds projected growth. Leans optimistic by design. Upside context.

5-yearinexpensive

By method

Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.

Method	Horizon	Est. price	Multiple	Per-share input	EPS source	Confidence
Peer P/FCF	12M	$6.71	18.5	0.36	TTM	medium
Peer P/FFO	12M	$42.23	14.8	2.85	TTM	medium
Peer P/S	12M	$42.59	6.0	7.10	TTM	medium
Own P/E history	12M	$17.43	71.4	0.24	TTM	medium
triangulated

P/E history

Monthly trailing P/E with quartile reference lines.

75 monthly points available

Coming next

A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.